cvs yeztugo - Search News

News

CVS, HIV and Gilead

Exclusive: CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness.

Yahoo Finance · 1d

Gilead stock falls after CVS holds off adding HIV prevention shot to plans

Gilead Sciences (NASDAQ:GILD) stock fell 2.7% in pre-market trading Thursday after reports that CVS Health (NYSE:CVS) will not add the company’s new HIV prevention drug, Yeztugo, to its commercial plans for now.

Fierce Healthcare · 1d

For now, CVS declines to cover Gilead's long-acting HIV PrEP treatment Yeztugo

The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention breakthrough, at least for now. | CVS Health, the parent of PBM juggernaut CVS Caremark,

STAT1d

Pharmalittle: We’re reading about Gilead’s HIV drug, FDA speeding review of a rare disease drug, and more

CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's ...

WebMD1mon

How Yeztugo Works to Prevent HIV - WebMD

Yeztugo is only approved for use by itself to prevent HIV infections, not to treat it. But in order to use it, you will need to have a negative HIV test before you start and before each set of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

CVS, HIV and Gilead

Pharmalittle: We’re reading about Gilead’s HIV drug, FDA speeding review of a rare disease drug, and more

How Yeztugo Works to Prevent HIV - WebMD

Trending now